The Filing Desk

Apyx Medical vs LENSAR

Apyx Medical APYX · LENSAR LNSR · Health Care Equipment

LENSAR reported revenue of $58 million in fiscal 2025, about the same as Apyx Medical's $53 million in fiscal 2025. Apyx Medical's revenue grew 9.9% in its latest year, and LENSAR's grew 9.2%. Apyx Medical had an operating margin of -12.2%, against -42.1% at LENSAR. Free cash flow was −$9 million at Apyx Medical and −$15 million at LENSAR.

Side by side

Apyx MedicalLENSAR
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$53M$58M
Revenue growth9.9%9.2%
Revenue growth a year, last 5 years13.8%17.2%
Gross margin62.5%46.4%
Operating margin−12.2%−42.1%
Net margin−21.2%−58.7%
Free cash flow−$9M−$15M
Free cash flow margin−17.2%−25.5%
Return on capital−25.0%—
Net debt to EBITDA——
Dividends and buybacks$0M$0M
Change in diluted share count15.6%3.8%
Last close$2.39$4.64
P/E at the last close——
Insider trades, last 12 months—sold $169,989
Piotroski F-score4 of 9—
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
Apyx MedicalLENSAR
Operating margin
Percent of revenue
Apyx MedicalLENSAR
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
Apyx MedicalLENSAR

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Apyx Medical and LENSAR pages.